CD38 and hepatocellular carcinoma: Considering the concurrent expression of CD38 and PD-1 on HCC CD8+ TILs and its association with the higher HCC histological grades in our HCC cohort, targeting CD38 in combination with PD-1 blockade could revive the cytotoxic function of exhausted CD8+ TRM cells.